1. Home
  2. SMID vs CCCC Comparison

SMID vs CCCC Comparison

Compare SMID & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

N/A

Current Price

$34.58

Market Cap

211.2M

Sector

Industrials

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$3.12

Market Cap

185.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SMID
CCCC
Founded
1960
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.2M
185.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SMID
CCCC
Price
$34.58
$3.12
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$12.20
AVG Volume (30 Days)
4.0K
2.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
866.67
16.45
EPS
1.96
N/A
Revenue
$78,508,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.04
N/A
Revenue Growth
31.77
1.02
52 Week Low
$25.16
$1.09
52 Week High
$43.62
$3.64

Technical Indicators

Market Signals
Indicator
SMID
CCCC
Relative Strength Index (RSI) 45.72 62.58
Support Level $33.59 $2.14
Resistance Level $37.90 N/A
Average True Range (ATR) 1.45 0.35
MACD -0.09 0.09
Stochastic Oscillator 34.24 64.78

Price Performance

Historical Comparison
SMID
CCCC

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: